These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20043142)

  • 1. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
    Yang L; Wei J; He S
    Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.
    Yang L; Luo Y; Wei J; He S
    Int J Mol Med; 2010 May; 25(5):807-12. PubMed ID: 20372826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
    Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
    J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines.
    Witte K; Gruetz G; Volk HD; Looman AC; Asadullah K; Sterry W; Sabat R; Wolk K
    Genes Immun; 2009 Dec; 10(8):702-14. PubMed ID: 19798076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.
    Li M; Liu X; Zhou Y; Su SB
    J Leukoc Biol; 2009 Jul; 86(1):23-32. PubMed ID: 19304895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel interferon delta genes in mammals: cloning of one gene from the sheep, two genes expressed by the horse conceptus and discovery of related sequences in several taxa by genomic database screening.
    Cochet M; Vaiman D; Lefèvre F
    Gene; 2009 Mar; 433(1-2):88-99. PubMed ID: 19110041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.
    Haus O
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):95-100. PubMed ID: 10807049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
    Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
    PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative sequence analysis of cytokine genes from human and nonhuman primates.
    Villinger F; Brar SS; Mayne A; Chikkala N; Ansari AA
    J Immunol; 1995 Oct; 155(8):3946-54. PubMed ID: 7561102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral and antiproliferative effects of canine interferon-λ1.
    Ichihashi T; Asano A; Usui T; Takeuchi T; Watanabe Y; Yamano Y
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):141-6. PubMed ID: 24126210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of cytokines and interferon-related genes in the mouse embryo].
    Kita M; Tanaka K; Shinmura K; Tanaka Y; Liu Y; Imanishi J
    C R Seances Soc Biol Fil; 1994; 188(5-6):593-600. PubMed ID: 7540102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative integromics on BMP/GDF family.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 May; 17(5):951-5. PubMed ID: 16596286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
    Lasfar A; Lewis-Antes A; Smirnov SV; Anantha S; Abushahba W; Tian B; Reuhl K; Dickensheets H; Sheikh F; Donnelly RP; Raveche E; Kotenko SV
    Cancer Res; 2006 Apr; 66(8):4468-77. PubMed ID: 16618774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural comparison and chromosomal localization of the human and mouse IL-13 genes.
    McKenzie AN; Li X; Largaespada DA; Sato A; Kaneda A; Zurawski SM; Doyle EL; Milatovich A; Francke U; Copeland NG
    J Immunol; 1993 Jun; 150(12):5436-44. PubMed ID: 8099936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.
    Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
    J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7.
    Wang J; Walker H; Lin Q; Jenkins N; Copeland NG; Watanabe T; Burrows PD; Cooper MD
    Genomics; 1996 Apr; 33(2):167-76. PubMed ID: 8660964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved POU/OCT- and GATA-binding sites in 5'-flanking promoter region of mammalian WNT8B orthologs.
    Katoh M; Katoh M
    Int J Oncol; 2007 May; 30(5):1273-7. PubMed ID: 17390031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Mar; 17(3):529-32. PubMed ID: 16465403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.